[Early postoperative complications in patients with Moyamoya disease--a comparison of inhaled anesthesia with total intravenous anesthesia (TIVA)].

医学 烟雾病 麻醉 麻醉剂 异丙酚 外科
作者
Koko Adachi,Yoko Yamamoto,Eri Kameyama,Hirotoshi Suzuki,Takashi Horinouchi
出处
期刊:PubMed [National Institutes of Health]
卷期号:54 (6): 653-7 被引量:12
链接
标识
摘要

Moyamoya disease is a rare neurovascular disorder that requires special anesthetic managements during revascularization procedures. We have investigated the incidence of early postoperative complications under inhaled anesthesia in comparison with total intravenous anesthesia (TIVA) retrospectively.Seventy-two patients undergoing revascularization procedures were divided into two groups, one with inhaled anesthesia (n = 23) and the other with TIVA (n = 49). Surgical procedures were performed under normocapnia, proper body temperature, and all patients were prevented from anemia by homologous transfusion. To avoid the variance in anesthetic managements, 39 patients under 15 years of age were picked up and divided in the same way as above. Early postoperative complications including transient ischemic attack and cerebral infarction during the first 2 weeks after operation were investigated.In all patients, early postoperative complications occurred in 48% of inhaled anesthesia group and in 49% of TIVA group. In patients under 15, these complications occurred in 44% and in 57%, respectively. There was no significant difference in the incidence of complications between the two anesthetic groups.Several previous studies reported the excellence of TIVA for revascularization procedure on the basis of regional blood flow because inhaled anesthesia may provoke intracerebral steal in moyamoya disease. Our investigation in this study revealed that both anesthetic methods have no significant difference in postoperative complications during the first 2 weeks after operation. Thus further study should be needed to verify the safety of inhalation anesthetics in patients with moyamoya disease.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
changping应助Xmou采纳,获得10
刚刚
Molaison完成签到,获得积分10
1秒前
1秒前
老迟到的惜灵完成签到,获得积分20
1秒前
1秒前
难寻完成签到,获得积分10
3秒前
羡慕尽天的一天完成签到 ,获得积分10
3秒前
潇洒哥完成签到,获得积分10
3秒前
852应助高贵的亦竹采纳,获得10
3秒前
lcs完成签到,获得积分10
3秒前
CL完成签到,获得积分10
4秒前
zhuxl完成签到,获得积分10
4秒前
王心心完成签到 ,获得积分10
4秒前
wahahahha完成签到,获得积分10
4秒前
4秒前
贺雪发布了新的文献求助10
5秒前
5秒前
基金中中中完成签到,获得积分10
5秒前
yyy完成签到,获得积分10
5秒前
鸢华完成签到,获得积分10
6秒前
tantan发布了新的文献求助20
6秒前
论文多多完成签到,获得积分10
6秒前
6秒前
老苍完成签到,获得积分10
6秒前
科研通AI6.4应助int0采纳,获得10
6秒前
正直的怜菡完成签到,获得积分10
7秒前
00gi完成签到,获得积分10
7秒前
欣欣完成签到 ,获得积分20
7秒前
niu完成签到,获得积分10
7秒前
yuta123完成签到,获得积分10
7秒前
hj_tian完成签到,获得积分10
7秒前
科研小白完成签到,获得积分10
7秒前
li完成签到,获得积分10
7秒前
7秒前
李青松发布了新的文献求助10
8秒前
ww发布了新的文献求助10
8秒前
王某完成签到,获得积分10
8秒前
envdavid完成签到,获得积分10
8秒前
azuretimm完成签到,获得积分10
8秒前
花深粥完成签到 ,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Essentials of Carbohydrate Chemistry and Biochemistry, 4th Edition 800
Organizational Behavior 510
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
CLSI VET01S-2024 Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals (7th Ed) 500
DIPPR Project 801 - Full Version 380
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 化学工程 工程类 有机化学 物理 复合材料 生物化学 内科学 细胞生物学 基因 遗传学 免疫学 冶金 光电子学 癌症研究
热门帖子
关注 科研通微信公众号,转发送积分 7766181
求助须知:如何正确求助?哪些是违规求助? 9310092
关于积分的说明 20315074
捐赠科研通 7351008
什么是DOI,文献DOI怎么找? 3315033
关于科研通互助平台的介绍 2464576
邀请新用户注册赠送积分活动 2329603